NuCana is trading at $1.00, up +5.61%, with no clear catalyst identified for the November 9 pre-market rise.
- Its latest releases contain no new explanation; the most recent listed was the September 30 patent announcement.
- NuCana had also traded higher after hours on November 6; a November 7 report found no clear company-specific catalyst.
- A modestly positive market backdrop may contribute, but the evidence does not establish a direct cause.